We are live on ! Find out more
DMK

DMK Pharmaceuticals Corporation Common Stock
DMK

Delisted

DMK was delisted on the 6th of February, 2024.

Back to rankings

46 hedge funds and large institutions have $7.38M invested in DMK Pharmaceuticals Corporation Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,704% more call options, than puts

Call options by funds: $673K | Put options by funds: $24K

6% less funds holding

Funds holding: 49 → 46 (-3)

14% less capital invested

Capital invested by funds: $8.58M → $7.38M (-$1.2M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
13
Closed
7
Calls
$673K
Puts
$24K
Net Calls
+$649K
Net Calls Change
-$165K

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$69.2K
2
CCG
Capital CS Group
California
+$43.2K
3
Creative Planning
Creative Planning
Kansas
+$38.6K
4
State Street
State Street
Massachusetts
+$33.8K
5
BlackRock
BlackRock
New York
+$16.6K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$229K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$187K
3
VF
Virtu Financial
New York
-$136K
4
Millennium Management
Millennium Management
New York
-$84K
5
JP Morgan Chase
JP Morgan Chase
New York
-$82K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCA
26
Stonebridge Capital Advisors
Minnesota
$13K – – –
FCMT
27
Founders Capital Management (Texas)
Texas
$11K – – –
RW
28
RVW Wealth
California
$11K – – –
Principal Financial Group
29
Principal Financial Group
Iowa
$10K -$601 -14 -5%
AWS
30
Atria Wealth Solutions
New York
$9K +$9.19K +214 New
Victory Capital Management
31
Victory Capital Management
Texas
$8K -$343 -8 -3%
ACA
32
Affinity Capital Advisors
California
$8K – – –
Goldman Sachs
33
Goldman Sachs
New York
$7K -$4.33K -101 -36%
Squarepoint
34
Squarepoint
New York
$7K -$1.16K -27 -14%
OC
35
Oppenheimer & Co
New York
$7K – – –
Osaic Holdings
36
Osaic Holdings
Arizona
$7K – – –
Cetera Investment Advisers
37
Cetera Investment Advisers
Illinois
$6K – – –
MOS
38
MGO One Seven
Ohio
$6K – – –
WWM
39
Wolff Wiese Magana
California
$6K – – –
TF
40
TimeScale Financial
Massachusetts
$3K – – –
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$3K +$3.05K +71 New
AF
42
Allworth Financial
California
$2K – – –
Wells Fargo
43
Wells Fargo
California
$1K – – –
VF
44
Virtu Financial
New York
– -$136K -3,208 Closed
Millennium Management
45
Millennium Management
New York
– -$84K -1,981 Closed
AI
46
Atom Investors
Texas
– -$46K -1,074 Closed
Jane Street
47
Jane Street
New York
– -$25K -596 Closed
TSS
48
Two Sigma Securities
New York
– -$14K -327 Closed
HF
49
HRT Financial
New York
– -$12K -305 Closed
Wolverine Trading
50
Wolverine Trading
Illinois
– -$9K -209 Closed
1
2
3

DMK Hedge Fund Activity: Q1 2022 in Review

46 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in DMK Pharmaceuticals Corporation Common Stock (DMK) for Q1 2022, worth a combined $7.38M — down 14% from $8.58M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of DMK and 4 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 6 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $69.2K. The largest seller was Citadel Advisors, cutting an estimated $229K.

  • 46 institutional investors held DMK Pharmaceuticals Corporation Common Stock (DMK) as of Q1 2022, down from 49 in Q4 2021.
  • Funds reported $7.38M of DMK Pharmaceuticals Corporation Common Stock stock for Q1 2022, down 14% quarter-over-quarter.
  • 4 funds opened new DMK Pharmaceuticals Corporation Common Stock positions in Q1 2022 and 7 closed out, a net change of -3 holders.
  • The largest DMK Pharmaceuticals Corporation Common Stock buyer in Q1 2022 was Tower Research Capital (TRC), an estimated $69.2K added.
  • The largest DMK Pharmaceuticals Corporation Common Stock seller in Q1 2022 was Citadel Advisors, an estimated $229K sold.

Based on aggregated 13F filings for Q1 2022.